Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week
Lahontan Plans Drilling to Test Historic Waste Rock at Santa Fe - A Potential Source of Additional Low Cost Gold Production
Nevada Sunrise Completes Ground Gravity Survey at the Fivemile Gold Project, Cortez Mining District, Nevada
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
GoldInxs CEO Issues Letter to Shareholders, Highlights Progression of Maiden Drill Program at Fishpot Project
